Cargando…

Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27)

AIMS/HYPOTHESIS: Non-invasive diagnostic tools specific for pancreatic beta cells will have a profound impact on our understanding of the pathophysiology of metabolic diseases such as diabetes. The objective of this study was to use molecular imaging probes specifically targeting beta cells on human...

Descripción completa

Detalles Bibliográficos
Autores principales: Vats, D., Wang, H., Esterhazy, D., Dikaiou, K., Danzer, C., Honer, M., Stuker, F., Matile, H., Migliorini, C., Fischer, E., Ripoll, J., Keist, R., Krek, W., Schibli, R., Stoffel, M., Rudin, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411300/
https://www.ncbi.nlm.nih.gov/pubmed/22790173
http://dx.doi.org/10.1007/s00125-012-2605-2
_version_ 1782239807168053248
author Vats, D.
Wang, H.
Esterhazy, D.
Dikaiou, K.
Danzer, C.
Honer, M.
Stuker, F.
Matile, H.
Migliorini, C.
Fischer, E.
Ripoll, J.
Keist, R.
Krek, W.
Schibli, R.
Stoffel, M.
Rudin, M.
author_facet Vats, D.
Wang, H.
Esterhazy, D.
Dikaiou, K.
Danzer, C.
Honer, M.
Stuker, F.
Matile, H.
Migliorini, C.
Fischer, E.
Ripoll, J.
Keist, R.
Krek, W.
Schibli, R.
Stoffel, M.
Rudin, M.
author_sort Vats, D.
collection PubMed
description AIMS/HYPOTHESIS: Non-invasive diagnostic tools specific for pancreatic beta cells will have a profound impact on our understanding of the pathophysiology of metabolic diseases such as diabetes. The objective of this study was to use molecular imaging probes specifically targeting beta cells on human samples and animal models using state-of-the-art imaging modalities (fluorescence and PET) with preclinical and clinical perspective. METHODS: We generated a monoclonal antibody, 8/9-mAb, targeting transmembrane protein 27 (TMEM27; a surface N-glycoprotein that is highly expressed on beta cells), compared its expression in human and mouse pancreas, and demonstrated beta cell-specific binding in both. In vivo imaging was performed in mice with subcutaneous insulinomas overexpressing the human TMEM27 gene, or transgenic mice with beta cell-specific hTMEM27 expression under the control of rat insulin promoter (RIP-hTMEM27-tg), using fluorescence and radioactively labelled antibody, followed by tissue ex vivo analysis and fluorescence microscopy. RESULTS: Fluorescently labelled 8/9-mAb showed beta cell-specific staining on human and mouse pancreatic sections. Real-time PCR on islet cDNA indicated about tenfold higher expression of hTMEM27 in RIP-hTMEM27-tg mice than in humans. In vivo fluorescence and PET imaging in nude mice with insulinoma xenografts expressing hTMEM27 showed high 8/9-mAb uptake in tumours after 72 h. Antibody homing was also observed in beta cells of RIP-hTMEM27-tg mice by in vivo fluorescence imaging. Ex vivo analysis of intact pancreas and fluorescence microscopy in beta cells confirmed these findings. CONCLUSIONS/INTERPRETATION: hTMEM27 constitutes an attractive target for in vivo visualisation of pancreatic beta cells. Studies in mouse insulinoma models and mice expressing hTMEM27 demonstrate the feasibility of beta cell-targeted in vivo imaging, which is attractive for preclinical investigations and holds potential in clinical diagnostics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-012-2605-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-3411300
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-34113002012-08-23 Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27) Vats, D. Wang, H. Esterhazy, D. Dikaiou, K. Danzer, C. Honer, M. Stuker, F. Matile, H. Migliorini, C. Fischer, E. Ripoll, J. Keist, R. Krek, W. Schibli, R. Stoffel, M. Rudin, M. Diabetologia Article AIMS/HYPOTHESIS: Non-invasive diagnostic tools specific for pancreatic beta cells will have a profound impact on our understanding of the pathophysiology of metabolic diseases such as diabetes. The objective of this study was to use molecular imaging probes specifically targeting beta cells on human samples and animal models using state-of-the-art imaging modalities (fluorescence and PET) with preclinical and clinical perspective. METHODS: We generated a monoclonal antibody, 8/9-mAb, targeting transmembrane protein 27 (TMEM27; a surface N-glycoprotein that is highly expressed on beta cells), compared its expression in human and mouse pancreas, and demonstrated beta cell-specific binding in both. In vivo imaging was performed in mice with subcutaneous insulinomas overexpressing the human TMEM27 gene, or transgenic mice with beta cell-specific hTMEM27 expression under the control of rat insulin promoter (RIP-hTMEM27-tg), using fluorescence and radioactively labelled antibody, followed by tissue ex vivo analysis and fluorescence microscopy. RESULTS: Fluorescently labelled 8/9-mAb showed beta cell-specific staining on human and mouse pancreatic sections. Real-time PCR on islet cDNA indicated about tenfold higher expression of hTMEM27 in RIP-hTMEM27-tg mice than in humans. In vivo fluorescence and PET imaging in nude mice with insulinoma xenografts expressing hTMEM27 showed high 8/9-mAb uptake in tumours after 72 h. Antibody homing was also observed in beta cells of RIP-hTMEM27-tg mice by in vivo fluorescence imaging. Ex vivo analysis of intact pancreas and fluorescence microscopy in beta cells confirmed these findings. CONCLUSIONS/INTERPRETATION: hTMEM27 constitutes an attractive target for in vivo visualisation of pancreatic beta cells. Studies in mouse insulinoma models and mice expressing hTMEM27 demonstrate the feasibility of beta cell-targeted in vivo imaging, which is attractive for preclinical investigations and holds potential in clinical diagnostics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-012-2605-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer-Verlag 2012-07-13 2012 /pmc/articles/PMC3411300/ /pubmed/22790173 http://dx.doi.org/10.1007/s00125-012-2605-2 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Article
Vats, D.
Wang, H.
Esterhazy, D.
Dikaiou, K.
Danzer, C.
Honer, M.
Stuker, F.
Matile, H.
Migliorini, C.
Fischer, E.
Ripoll, J.
Keist, R.
Krek, W.
Schibli, R.
Stoffel, M.
Rudin, M.
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27)
title Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27)
title_full Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27)
title_fullStr Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27)
title_full_unstemmed Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27)
title_short Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27)
title_sort multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (tmem27)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411300/
https://www.ncbi.nlm.nih.gov/pubmed/22790173
http://dx.doi.org/10.1007/s00125-012-2605-2
work_keys_str_mv AT vatsd multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT wangh multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT esterhazyd multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT dikaiouk multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT danzerc multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT honerm multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT stukerf multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT matileh multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT migliorinic multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT fischere multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT ripollj multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT keistr multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT krekw multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT schiblir multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT stoffelm multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27
AT rudinm multimodalimagingofpancreaticbetacellsinvivobytargetingtransmembraneprotein27tmem27